STX140
Product Specifications
UNSPSC Description
STX140 is an orally active microtubule disruptor. STX140 induces apoptosis in the hormone-independent PC-3 prostate cell lines. STX140 has anti-angiogenic and anti-tumour activities[1].
Target Antigen
Apoptosis; Estrogen Receptor/ERR; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Apoptosis;Cell Cycle/DNA Damage;Cytoskeleton;Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/stx140.html
Smiles
C[C@@]12[C@](CC[C@@H]2OS(N)(=O)=O)([H])[C@@]3([H])[C@@](CC1)([H])C4=CC(OC)=C(OS(N)(=O)=O)C=C4CC3
Molecular Weight
460.56
References & Citations
[1]S P Newman, et al. The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers. Br J Cancer. 2007 Dec 17;97(12):1673-82.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-133222/STX140-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-133222/
Clinical Information
Phase 2
CAS Number
401600-86-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6349006-01 0.1 mL
SMOC1, CT (SMOC1, SPARC-related modular calcium-binding protein 1, Secreted modular calcium-binding protein 1) (MaxLight 405)
Ask
View Details MBS6349006-02 5x 0.1 mL
SMOC1, CT (SMOC1, SPARC-related modular calcium-binding protein 1, Secreted modular calcium-binding protein 1) (MaxLight 405)
Ask
View Details 
TP301838M 100 µg
Asparagine synthetase (ASNS) (NM_183356) Human Recombinant Protein
Ask
View Details